Predicted Trait | |
Reported Trait | Thyroid cancer |
Mapped Trait(s) | thyroid carcinoma (EFO_0002892) |
Score Construction | |
PGS Name | cGRS_Thyroid |
Development Method | |
Name | Pruning and Thresholding (P+T) |
Parameters | GWAS significant and r2 < 0.2. PGS levels were computed as product(dosage*weight/expected risk effect), where the expected risk effect for each variant was calculated based on the risk allele frequence (f) and risk allele weight (OR) as f^2*OR^2 + 2f(1-f)OR + (1-f)^2. |
Variants | |
Original Genome Build | NR |
Number of Variants | 6 |
Effect Weight Type | Odds Ratio over expected risk |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000075 |
Citation (link to publication) | Shi Z et al. Cancer Med (2019) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 100% 355,697 individuals (100%) |
PGS Evaluation | European: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST004144 Europe PMC: 28195142 |
290,551 individuals | European | NR |
GWAS Catalog: GCST001382 Europe PMC: 222672 |
27,758 individuals | European | NR |
GWAS Catalog: GCST000335 Europe PMC: 19198613 |
37,388 individuals | European | NR |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM000493 | PSS000282| European Ancestry| 13,814 individuals |
PGP000075 | Shi Z et al. Cancer Med (2019) |
Reported Trait: Thyroid cancer | — | — | Odds Ratio (OR; high vs. average risk groups): 1.7 [1.29, 2.25] | — | — |
PPM000482 | PSS000282| European Ancestry| 13,814 individuals |
PGP000075 | Shi Z et al. Cancer Med (2019) |
Reported Trait: Thyroid cancer | — | — | Mean realative risk: 1.09 [1.04, 1.15] Wilcoxon test (case vs. control) p-value: 4e-05 |
— | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS000282 | Primary tumor samples from TCGA | — | [
|
Mean = 49.0 years Sd = 16.0 years |
European | — | TCGA | — |
PSS000282 | — | — | [
|
— | European | — | eMERGE | — |